Medical Press Release - Page 8 of 12 - Medika Life : Keeping you informed

TCA/GENETWORx is building capability to perform 870,000 tests per day or 26 million per month. In order to meet demand, the company launched a massive recruiting campaign called Re Employ America

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Medika Life - September 13, 2020

Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

Medika Life - October 22, 2021

Digital Salutem is delighted to announce that digital health influencers, Gil Bashe and Stacy Hurt, have joined ours team as board members

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life - May 13, 2021

The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

FINN Partners Brings Aboard the Pharmacy Podcast Network

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

COVID-19 Testing with 72 Hour or Less Turnaround Time

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories